Find Jobs At The Best Companies For You

Where do you want to work?

0 selections

Decibel Therapeutics Overview

Translating rapid advances in hearing science to meet the urgent needs of hundreds of millions worldwide with disabling hearing loss.
Decibel Therapeutics is a small health care company based in Boston, MA with only 75 employees and an annual revenue of $8.5M.







Founded in



Boston, MA


Organization Type


Is This Your Company?

The Team At Decibel Therapeutics

Key People
  • John Keilty (Executive Officer)
  • Jeffrey Jonas (Director)
  • Jens Eckstein (Director)
  • Roger Brown (Director)
  • Troy Brennan (Director)
  • George Scangos (Director)
  • Kevin Starr (Director)
  • Craig Muir (Director)
  • Steven Holtzman (Executive Officer, Director)

What do people say about Decibel Therapeutics

Work at Decibel Therapeutics? Share your experience anonymously.

What do you like about working for Decibel Therapeutics?

Decibel Therapeutics Rankings

Decibel Therapeutics is ranked #83 on the Best Start-up Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Do you Work At Decibel Therapeutics?

Help us make this company more transparent.

Decibel Therapeutics Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.


$5M - $10M

Founded in


Organization type


Decibel Therapeutics Financing Rounds

DateascdescAmountascdescSecurity Typeascdesc
Jan 13, 2017Equity
Jan 13, 2017

How Would You Rate The Company Culture Of Decibel Therapeutics?

Have you worked at Decibel Therapeutics? Help other job seekers by rating Decibel Therapeutics.

Frequently Asked Questions about Decibel Therapeutics

When was Decibel Therapeutics founded?

Decibel Therapeutics was founded in 2015.

How many Employees does Decibel Therapeutics have?

Decibel Therapeutics has 75 employees.

How much money does Decibel Therapeutics make?

Decibel Therapeutics generates $8.5M in revenue.

What industry is Decibel Therapeutics in?

Decibel Therapeutics is in the biotechnology industry.

What type of company is Decibel Therapeutics?

Decibel Therapeutics is a private company.

Who are Decibel Therapeutics's competitors?

Decibel Therapeutics competitors include BioTork, Evolve Biosystems, Purigen Biosystems, Serimmune, ABSCI, Intuitive Biosciences, Effector Therapeutics, Modern Meadow, DIRAmed, Metabolic Solutions Development Company, McGinley Orthopaedic Innovations, RDMD, EpiCypher, Sharklet Technologies, Dermala, Vedanta Biosciences, Geneticure, Single Cell Technology, Insilico Medicine, Enginuity Worldwide.

Who works at Decibel Therapeutics?

John Keilty (Executive Officer)

Jeffrey Jonas (Director)

Jens Eckstein (Director)

Show More

Where is Decibel Therapeutics's headquarters?

Decibel Therapeutics's headquarters is in Boston, MA.

Are You An Executive, HR Leader, Or Brand Manager At Decibel Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Updated December 31, 2020

Zippia gives an in-depth look into the details of Decibel Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Decibel Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Decibel Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Decibel Therapeutics and its employees or that of Zippia.

Decibel Therapeutics may also be known as or be related to DECIBEL THERAPEUTICS INC, Decibel Therapeutics, Decibel Therapeutics Inc and Decibel Therapeutics, Inc.